Skip to main content
Xspray Pharma logo

Xspray Pharma — Investor Relations & Filings

Ticker · XSPRAY ISIN · SE0023312764 LEI · 549300NGRQCNZ3X4L157 ST Manufacturing
Filings indexed 254 across all filing types
Latest filing 2026-05-12 Declaration of Voting R…
Country SE Sweden
Listing ST XSPRAY

About Xspray Pharma

https://xspraypharma.com/

Xspray Pharma is a pharmaceutical company that utilizes its patented technology platform to develop improved versions of marketed drugs, primarily focusing on Protein Kinase Inhibitors (PKIs) for cancer treatment. The company's core innovation lies in its ability to create stable, amorphous (non-crystalline) formulations of active pharmaceutical ingredients. This unique approach enables the development of product candidates that can bypass the secondary patents of original crystalline drugs, facilitating market entry upon the expiration of the primary substance patent. Xspray Pharma's products are designed to offer clinical benefits for patients compared to the original branded drugs and their subsequent generic equivalents.

Recent filings

Filing Released Lang Actions
Kommuniké från årsstämma i Xspray Pharma AB (publ) 12 maj 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is a press release summarizing the resolutions and voting outcomes from the Xspray Pharma AB annual general meeting held on 12 May 2026. It lists decisions on approval of accounts, discharge of liability, dividend, board and auditor elections, incentive programs, and share issuance authorizations—all outcomes of shareholder votes. This fits the “Declaration of Voting Results & Voting Rights Announcements” category.
2026-05-12 Swedish
Bulletin from the annual general meeting of Xspray Pharma AB (publ) 12 May 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a press release titled “Bulletin from the annual general meeting of Xspray Pharma AB (publ) 12 May 2026” summarizing the resolutions passed at the AGM (adoption of financials, board elections, LTIP programs, share authorizations, etc.). It is not the full AGM slide deck or financial report itself but an official announcement of the voting outcomes and resolutions from the AGM. Hence it fits the “Declaration of Voting Results & Voting Rights Announcements” category (DVA).
2026-05-12 English
Regulatory Filings 2026
Regulatory Filings
2026-05-04 Swedish
Nytt antal aktier och röster i Xspray Pharma efter nyemission april 2026
Regulatory Filings
2026-04-30 Swedish
New number of shares and votes in Xspray Pharma after new share issue April 2026
Regulatory Filings
2026-04-30 English
Interim / Quarterly Report 2026
Interim / Quarterly Report Q1 2026
2026-04-28 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.